Rajiv Patni serves as Executive at Ocera Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Rajiv Patni has executed 12 insider transactions totaling $84.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 9, 2026 involved receiving (via award) 17,000 shares valued at $0.
Rajiv Patni currently holds 17,000 shares of Ocera Therapeutics, Inc. (OCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rajiv Patni has been a net seller of OCRX stock. They have purchased $20.0K and sold $64.0K worth of shares.
Rajiv Patni's most recent insider trade was on Jan 9, 2026, when they sold 17,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 12, 2023 | RETA | $0 | Award | 45,000 | $N/A | Discretionary |
| Feb 28, 2020 | PTLA | $0 | Award | 35,000 | $N/A | Discretionary |
| Apr 8, 2019 | ADMS | $0 | Award | 30,000 | $N/A | Discretionary |
| Mar 20, 2019 | ADMS | $19.0K | Sale | 2,374 | $8.00 | Discretionary |
| Mar 21, 2018 | ADMS | $32.5K | Sale | 1,252 | $25.94 | Discretionary |
| Mar 6, 2018 | ADMS | $0 | Award | 9,125 | $N/A | Discretionary |
| Mar 21, 2017 | ADMS | $12.5K | Sale | 733 | $17.04 | Discretionary |
| Jan 18, 2017 | ADMS | $0 | Award | 6,875 | $N/A | Discretionary |
| Mar 4, 2016 | ADMS | $102.5K | Award | 7,500 | $13.66 | Discretionary |
| May 7, 2015 | OCRX | $20.0K | Purchase | 5,050 | $3.97 | Discretionary |